Boaz Adler

Director of Global Product Engagement

Boaz joined the team at Cytel in 2021 and is a member of the ​​Cytel Innovation Advisory Board. For more than a decade, he has served as a Solutions Consultant and Analyst for Life Sciences companies and Health Tech organizations. His interests are focused on tech and novel service innovations that contribute to more coherent and robust evidence generation across the drug development cycle.

At Cytel, Boaz enhances the connection between Cytel’s software development team and its clients and supports clients in clinical trial optimization projects using Cytel’s cutting-edge technology. He is passionate about his clients’ success and about the personal and professional success of his team and their contributions to the company.

Boaz has a BA in History and an MPA in Healthcare Finance and Policy from Baruch College.

Boaz Adler

Related Articles

Vaccine Efficacy Trials: Design Considerations and Simulation Tools
Blog
novembre 26, 2024
Vaccine Efficacy Trials: Design Considerations and Simulation Tools
Read More
The Importance of Simulation in Designing Fixed-Sample Clinical Trials
Blog
octobre 8, 2024
The Importance of Simulation in Designing Fixed-Sample Clinical Trials
Read More
Oncology Clinical Trials: Design Trends in Biomarker Research
Blog
août 20, 2024
Oncology Clinical Trials: Design Trends in Biomarker Research
Read More
Why Simulate Study Design at a Large Scale? Leveraging Cloud Computing for Confident Results
Blog
mai 23, 2024
Why Simulate Study Design at a Large Scale? Leveraging Cloud Computing for Confident Results
Read More